Patrick W. Domkowski, G. Chad Hughes, John E. Scarborough, Luis H. Diodato, Monica L. Smith, Kevin P. Landolfo, and James E. Lowe
Transmyocardial laser revascularization (TMR) is emerging as a potential treatment option for path end-stage coronary artery disease who are not candidates for coronary
angioplasty or bypass surgery.
Access to the full text of this article is restricted. In order to view this article please log in.